Investor Presentaiton slide image

Investor Presentaiton

1-4. Operating Income by Segment!HE KAITEKI COMPANY Fiscal 2013 Actual Results vs. Fiscal 2014 Forecasts ■Designed Materials: Conditions firm ■Health Care: Conditions firm for pharmaceuticals and healthcare solutions Polymers: Outlook for major increase in income in MMA/PMMA FY2013 Domains Segments actual results FY2014 forecasts* Change Accumulated through 3Q** Target attainment ratio Electronics Applications (5.5) (2.0) +3.5 (2.3) • Performance Products Designed Materials • 46.5 55.5 +9.0 41.7 75.1% Health Care Health Care 68.3 70.0 +1.7 70.7 101% Operating income (\ billion) Comments Consolidation of TNSC (Chemicals) [3Q fiscal 2014] Outlook for inventory valuation loss* for naphtha and paraxylene in Chemicals and marginal gain* for polyolefin in Polymers [3Q and 4Q fiscal 2014] • Outlook for increase in income in Designed Materials, Health Care, and Polymers Chemicals 0.7 17.5 +16.8 2.2 12.6% Industrial Materials *Overall impact: (Approx. ¥18.0 billion) Polymers 2.3 20.5 +18.2 13.7 66.8% Notes: Others 5.7 6.5 + 0.8 3.3 50.8% Corporate (7.5) (8.0) (0.5) (5.0) Total 110.5 160.0 + 49.5 124.3 77.7% Includes effects of adopting uniform date for account closings in fiscal 2013: Net sales: ¥151.9 billion; Operating income: ¥3.9 billion) Includes effects of consolidating TNSC in fiscal 2014: Net sales: ¥275.0 billion; Operating income: ¥17.5 billion *Figures announced Nov. 27, 2014 **Figures announced Feb. 4, 2015 8
View entire presentation